Article
Myelodysplastic Syndrome in a Case of New-onset Pancytopenia
Internal Medicine
Division
West Florida
Hospital
Largo Medical Center
Document Type
Case Report
Publication Date
3-1-2022
Keywords
- myelodysplastic syndrome,
- pancytopenia,
- piperacillin/tazobactam‐induced immune response,
- vaccine‐associated pancytopenia
Disciplines
Abstract
Myelodysplastic syndrome (MDS) is an infrequent cause of pancytopenia, which is a decrease in all three peripheral blood cell lines. We report the case of new-onset pancytopenia following administration of a COVID-19 vaccine and recurrent Zosyn use who was later found to have myelodysplastic syndrome.
Publisher or Conference
Clinical Case Reports
Citation Information
Lancaster I, Patel D, Sethi V, Connelly W, Namey J. Myelodysplastic syndrome in a case of new-onset pancytopenia. Clin Case Rep. 2022;10(3):e05533. doi:10.1002/ccr3.5533